November 4, 2025/
This document is an official communication from the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). It summarizes the outcomes of their safety review meeting held...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
This document is an official communication from the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). It summarizes the outcomes of their safety review meeting held...
Medication safety is a critical discipline within healthcare dedicated to preventing errors and mitigating harm associated with the use of medicines throughout the entire medication use...
Explanation of Patient Engagement, with a specific focus on its role and growing importance in Pharmacovigilance (PV).
